Avoiding CCP False Positives in Rheumatoid Arthritis Diagnosis

rheumatoid-arthritis-diagnosis-webinar

Event Details

Originally Aired: October 24, 2016
Time: 11 a.m. ET
Presenter: Teresa Tarrant, MD

Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.

Optimize RA Testing Protocols

Join our upcoming PACE-accredited webinar on avoiding CCP false positives in the diagnosis of rheumatoid arthritis — the second most common autoimmune disease just behind autoimmune thyroid diseases, and more common than antiphospholipid syndrome and autoimmune liver diseases.

Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that afflicts between 1.3 and 2.6 million adults and approximately 294,000 children in the United States and an estimated 0.2-0.5 percent of Canadians. Its cause is unknown and there is no cure, but early treatment can help prevent irreversible joint damage and elevate an RA patient’s quality of life.

Learning Objectives

This important online presentation will help participants:

  • Understand evidence-based approaches described in the American College of Rheumatology guidelines for the diagnosis and management of rheumatoid arthritis
  • Identify the importance of specificity in test selection, and the optimal usage of two recommended serologic markers for rheumatoid arthritis — anti-CCP and rheumatoid factor IgM
  • Recognize how test efficacy and disease prevalence impact the accuracy of results, and when to consult with or refer the patient

rheumatoid-arthritis-webinar-speaker-teresa-tarrant

About the Presenter

Teresa Tarrant, MD

Assistant Professor of Medicine at Duke University School of Medicine

Dr. Tarrant is a clinical immunologist, board-certified in allergy, immunology and rheumatology. She specializes in diseases of and related to rheumatoid arthritis, Sjögrens syndrome, inflammatory eye disease, CVID, and immunodeficiency in aging.

After graduating from the University of Florida College of Medicine, Dr. Tarrant performed her fellowship and residency at Duke University Hospital in North Carolina. In addition to her active medical practice, Dr. Tarrant has held two other major roles in her daily work: first as a medical liaison, where she assists in the evaluation and selection of immunoassays, including authoring or co-authoring peer-reviewed scientific articles of their evaluations, and second as an associate professor of medicine.